KLOTHO NEUROSCIENCES INC (KLTO) Stock News

USA - Nasdaq - NASDAQ:KLTO - US49876K1034 - Common Stock

0.4752 USD

+0.03 (+5.6%)

Last: 11/28/2025, 7:42:55 PM

0.475 USD

0 (-0.04%)

After Hours: 11/28/2025, 7:42:55 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

KLTO Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill - Mentions: DK BEAT OC IFRX ...

News Image

Get insights into the top gainers and losers of Friday's after-hours session.

22 days ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

2 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Announces Expiration of Letter of Intent

2 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

3 months ago - By: Klotho Neurosciences, Inc.

CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar

3 months ago - By: Klotho Neurosciences, Inc.

Le PDG de Klotho Neurosciences participera à la conférence inaugurale et au séminaire scientifique

3 months ago - By: Klotho Neurosciences, Inc.

CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil

3 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

3 months ago - By: Benzinga - Mentions: NBY PHR IMCC PMN ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

3 months ago - By: Benzinga - Mentions: CERO NXTT CPRT BRIA ...

Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

3 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

4 months ago - By: Klotho Neurosciences, Inc.

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

4 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

4 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

5 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

5 months ago - By: Stocktwits

Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy

5 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

5 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population